Sustainability & Climate

The largest World Cup ever brings complex risks. A new guide from Safeture and Riskline offers fans and firms the intel needed to travel safely.

Tech giant HPE secures access to next-gen Wi-Fi 6 and 7 tech via Sisvel's patent pool, a move that validates collaborative IP and speeds innovation.

Former Biosynth CEO Dr. Urs Spitz joins Ribbon Bio, signaling a major push to commercialize its groundbreaking cell-free DNA synthesis platform.

A new alliance between Daiichi Sankyo and ATLATL aims to leverage a unique 'Super Server' model to fast-track novel therapies from Asia to the world.

As global tech leaders convene, Hong Kong aims to cement its role as a digital super-connector amid rising debates on AI governance and cross-border data.

As MasterBrand preps its Q1 2026 results, investors watch to see if cost cuts and new trends can counter a tough housing and renovation market.

Facing credit defaults and a failed asset sale, the Western Canadian environmental services firm is now under court protection, seeking buyers for its business.

A new certification for AI-guided cardiac ultrasound seeks to solve the training and trust gap, making crucial heart scans more accessible for frontline providers.

After a rare Q4 earnings miss rattled investors, pest control giant Rollins, Inc. sets its Q1 2026 report date. Can the company prove its growth story is intact?

A landmark deal sends Montana hemp to Vietnam, forging a transparent, green supply chain for fashion and offering a lifeline to US farmers.

Following positive safety data, Phanes Therapeutics expands trials for spevatamig, a first-in-class antibody targeting two cancer pathways at once.

Ress Life Investments reports a 1.7% NAV gain but sheds $84M in assets, pivoting to an earnout model. What does this mean for the life settlement market?

The Oklahoma drinkware giant integrates philanthropy into its DNA, pledging $1.8M for 2026 and showcasing a unique model for corporate giving.

Lupin wins FDA approval for its generic dapagliflozin, a move set to slash costs for a blockbuster diabetes and heart drug and reshape patient care.

A new survey reveals a paradox: while most Americans use online health tools, few trust them, highlighting the crucial role of human healthcare providers.

Following a viral two-hour sellout, Rachel Mansfield's cadootz! has secured over $3M to expand its ultra-clean kids' crackers into major retail.

Grön's new PIXLZ gummies blend Y2K nostalgia with advanced cannabis science, aiming to reprogram the edible experience with mode-based, sensory effects.

A new independent study shows AVID Excel nearly doubles reclassification rates for long-term English learners, offering a proven path to academic success.

An Arizona summit connects builders with new talent, using tech and mental health initiatives to solve the industry's critical workforce shortage.

A new minimally invasive stent for complex aortic arch disease receives FDA approval, offering hope to high-risk patients previously deemed untreatable.